AQST three-lens brief
Evidence-based stock research on AQST. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -3.11% yesterday. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Moved -3.11% yesterday.
- Outperforming SPY by 34.7pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $9.33 — 87% above current (9 analysts).
- Negative free cash flow last quarterly (-$26.89M).
AQST closed at $4.99 (-3.11%) as of 2026-09-11. Market cap: $626.30M. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 34.7pp over 30 days.; analyst mean target $9.33 — 87% above current (9 analysts).. Concerns: moved -3.11% yesterday.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $13.82M, net income -$22.86M, free cash flow -$26.89M.
Why three lenses on AQST, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AQSTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AQST" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AQST brief"></iframe>